​

Skye Bioscience (SKYE) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

SKYE Stock Forecast

Skye Bioscience (SKYE) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $19.00, with a high of $21.00 and a low of $15.00. This represents a 779.63% increase from the last price of $2.16.

- $5 $10 $15 $20 $25 High: $21 Avg: $19 Low: $15 Last Closed Price: $2.16

SKYE Stock Rating

Skye Bioscience stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

SKYE Price Target Upside V Benchmarks

TypeNameUpside
StockSkye Bioscience779.63%
SectorHealthcare Stocks 27.56%
IndustryBiotech Stocks 68.41%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$16.50
Last Closing Price$2.16$2.16$2.16
Upside/Downside--663.89%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2534---7
May, 2534---7
Apr, 2534---7
Mar, 2534---7
Feb, 2534---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 10, 2024Jonathan WollebenJMP Securities$15.00$6.35136.22%594.44%
Aug 26, 2024Albert LoweCraig-Hallum$18.00$5.97201.51%733.33%
Jun 10, 2024Jay OlsonOppenheimer$21.00$9.98110.42%872.22%
May 23, 2024Kristen KluskaCantor Fitzgerald$21.00$11.9875.29%872.22%
Apr 11, 2024Jay OlsonOppenheimer$25.00$12.6997.01%1057.41%
Mar 14, 2024Edward TenthoffPiper Sandler$20.00$12.9055.04%825.93%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 27, 2025William BlairOutperforminitialise
Sep 30, 2024ScotiabankOutperforminitialise
Sep 20, 2024Cantor FitzgeraldOverweightOverweighthold
Sep 10, 2024JMP SecuritiesOutperforminitialise
Aug 26, 2024Craig-HallumBuyBuyhold
Jul 09, 2024Craig-HallumBuyinitialise
Jun 10, 2024OppenheimerOutperformOutperformhold
May 23, 2024Cantor FitzgeraldOverweightinitialise
Apr 11, 2024OppenheimerOutperforminitialise

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-5.37$-0.73---
Avg Forecast$-5.43$-0.64$-1.18$-1.44$-1.90
High Forecast$-5.43$-0.50$-1.08$-1.11$-1.40
Low Forecast$-5.43$-0.84$-1.33$-1.69$-2.59
Surprise %-1.10%14.06%---

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported-----
Avg Forecast-----
High Forecast-----
Low Forecast-----
Surprise %-----

Net Income Forecast

$-95M $-79M $-63M $-47M $-31M $-15M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-37.65M$-26.57M---
Avg Forecast$-38.04M$-24.45M$-43.05M$-55.08M$-75.29M
High Forecast$-38.04M$-18.24M$-39.41M$-40.50M$-51.08M
Low Forecast$-38.04M$-30.65M$-48.53M$-61.66M$-94.50M
Surprise %-1.05%8.67%---

SKYE Forecast FAQ

Is Skye Bioscience stock a buy?

Skye Bioscience stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Skye Bioscience is a favorable investment for most analysts.

What is Skye Bioscience's price target?

Skye Bioscience's price target, set by 4 Wall Street analysts, averages $19 over the next 12 months. The price target range spans from $15 at the low end to $21 at the high end, suggesting a potential 779.63% change from the previous closing price of $2.16.

How does Skye Bioscience stock forecast compare to its benchmarks?

Skye Bioscience's stock forecast shows a 779.63% upside, outperforming the average forecast for the healthcare stocks sector (27.56%) and outperforming the biotech stocks industry (68.41%).

What is the breakdown of analyst ratings for Skye Bioscience over the past three months?

  • June 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Skye Bioscience’s EPS forecast?

Skye Bioscience's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.18, marking a 61.64% increase from the reported $-0.73 in 2024. Estimates for the following years are $-1.44 in 2026, and $-1.9 in 2027.

What is Skye Bioscience’s revenue forecast?

Skye Bioscience's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, and $0 for 2027.

What is Skye Bioscience’s net income forecast?

Skye Bioscience's net income forecast for the fiscal year ending in December 2025 stands at $-43.055M, representing an 62.06% increase from the reported $-26.567M in 2024. Projections indicate $-55.075M in 2026, and $-75.289M in 2027.